Ad5Ag85A

N/A

Report date: 2022/11/18 17:53:04

Base Information

Drug NameAd5Ag85A
Drug Alias NameRecombinant genetic TB vaccine Ad5Ag85ATB vaccine candidate,Recombinant-deficient human adenoviral TB vaccineAdAg85AAd5-Ag85A
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMcmaster University
China Registration ClassN/A

Develop Information

Active CompaniesPT Etana Biotechnologies IndonesiaAerasMcmaster University
Inactive CompaniesN/A
Active IndicationsTuberculosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A